© 2023 MJH Life Sciences™ and Drug Topics. All rights reserved.
Take a look back at our most popular dermatology coverage for 2022.
The drug has previously been approved to treat moderately to severely active rheumatoid arthritis.
Ruxolitinib cream 1.5% may soon be the first FDA-approved treatment for repigmentation of vitiligo. Experts share what dermatologists need to know regarding efficacy, safety, and cost of this topical drug.
Protection from the harsh rays of the sun is crucial for everyone—including children. Now that summer has arrived, a refresher course can go a long way in preventing skin damage and disorders due to the sun.
Examining the results of a study examining the role of supplements and diets in managing psoriasis.
As skin manifestations are commonly the first thing spotted with infectious disease, dermatologists are in a great position to counsel patients about prevention.
New options are being developed for conditions including psoriatic arthritis, ulcerative colitis, and asthma.
The education on how to treat patients with skin issues in this group needs to be expanded so providers can better treat patients.